Please login to the form below

Not currently logged in

Janssen launches UK blood cancer awareness campaign

The pharma group join forces with designer to set up ‘giant’ names in London

Blood cancer names

Janssen Pharmaceuticals has launched a new campaign to raise awareness of the 137 variations of blood cancer, including leukaemia, lymphoma and multiple myeloma.

The Make Blood Cancer Visible campaign coincides with blood cancer awareness month and is backed by nine blood cancer patient support groups.

It involves the creation by designer Paul Cocksedge of 104 ‘giant’ names of patients with the disease, representing the exact number of individuals diagnosed with blood cancer every day.

The names - which are sized to match each patient’s height - will be placed in Paternoster Square in London where members of the public can engage with the patient’s experience of blood cancer.

Dr Rozlyn Bekker, Janssen UK’s business unit director for oncology and haematology, said: “Janssen is dedicated to supporting and improving the lives of patients diagnosed with blood cancer.

“Helping to raise awareness of these types of cancers and working with healthcare professionals and patient support groups to bring about a better understanding of haematological malignancies is an important part of this.

“We hope this campaign will help to give a voice to patients living with blood cancer.”

Blood cancer is the fifth most commonly diagnosed cancer in the UK with approximately 1 in 25 diagnosed with the disease at some point in their life.

Diana Jupp, director of patient experience at Bloodwise, said: “Despite 230,000 people being affected by blood cancer across the UK, it is still a much misunderstood and little-known disease area.”

Results of a public survey conducted by YouGov and funded by Janssen were revealed to coincide with the campaign.

According to the survey, only one in ten people are aware that there are over 100 different types of blood cancer, and only 12% of people selected blood cancer as one of the top five most commonly diagnosed types of cancer.

Jupp added: “We know that low awareness can lead to late diagnosis and can make it hard for people to find the information and support they need, leading to a greater sense of isolation.

We are therefore delighted to be a part of this exciting campaign helping to raise awareness of blood cancer throughout this September and it’s great to see so many patient support groups join forces to all do their bit to make blood cancer visible.”

In an earlier iteration Janssen’s campaign was a finalist at the 2017 Communiqué awards.

Article by
Gemma Jones

4th September 2017

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...